Clinical Trials Directory

Trials / Completed

CompletedNCT03180892

Non-immune Related Hypothyroidism in Iodine Sufficient Area

Status
Completed
Phase
Study type
Observational
Enrollment
6,564 (actual)
Sponsor
Samsung Medical Center · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

Background: Autoimmune hypothyroidism has been regarded as the most common cause of primary hypothyroidism in iodine sufficient area and has relationship with excess iodine induced hypothyroidism. However, non-immune related hypothyroidism and its relationship with excess iodine have been rarely evaluated. Objective: Therefore, the investigators planned to calculate proportion of non-immune related hypothyroidism and relationship with iodine intake using nationwide data from Korea National Health and Nutrition Examination Survey (KNHANES) 2013-2015. Design: 1. Korea National Health and Nutrition Examination Survey VI (2013 to 2015) - The national data - which is the government designated statistics (Approval No. 117002 ) of South Korea based on the Article 17 of the National Health Promotion Act - were used. The survey was approved by the Institutional Review Board of the Korea Centers for Disease Control and Prevention, and provides only non-identified measures for academic research purposes. 2. The participants who were examined for thyroid stimulating hormone, free thyroxine, thyroid peroxidase antibody (TPO Ab), and urine iodine concentration (UIC) were included. 3. The proportion of immune related and non-immune related hypothyroidism was evaluated. Demographic variables and severity of hypothyroidism were compared between the two groups. To analyze iodine effect on hypothyroidism in TPO Ab positive or negative population, prevalence of hypothyroidism were assessed in each TPO Ab negative and positive population according to UIC subgroups. 4. This study protocol was approved by IRB of SMC (2017-05-149).

Conditions

Interventions

TypeNameDescription
OTHERThe investigators did not apply any intervention for the participants.The investigators did not apply any intervention for the participants.

Timeline

Start date
2013-01-01
Primary completion
2016-12-31
Completion
2016-12-31
First posted
2017-06-08
Last updated
2017-06-09

Source: ClinicalTrials.gov record NCT03180892. Inclusion in this directory is not an endorsement.